Controls (n = 44) | MVP (all) (n = 80) | MVP (No significant MR) (n = 34) | “Borderline” (n = 13) | |
---|---|---|---|---|
Age (y) | 46 [38–57] | 52 [40–63]* | 50 [35–59] | 51 [36–63] |
Male | 23 (52%) | 37 (46%) | 14 (41%) | 7 (50%) |
BSA (m2) | 1.9 [1.7–2.1] | 1.7 [1.6–2.0]* | 1.7 [1.6–2.0]* | 1.8 [1.6–1.9]* |
Hypertension | 18/42 (43%) | 27/73 (37%) | 10/31 (32%) | 1/9 (11%) |
Diabetes mellitus | 5/42 (12%) | 0/51 (0%) | 0/23 (0%) | 1/13 (13%) |
Current or former smoker | 13/42 (31%) | 13/50 (26%) | 6/23 (26%) | 0/9 (0%)* |
Dyslipidemia | 12/42 (29%) | 16/52 (31%) | 7/23 (30%) | 2/9 (22%) |
Obesity | 10/42 (23%) | 6/80 (8%)** | 3/34 (9%)* | 0/13 (0%)* |
Family history of MVP (%) | 0/41 (0%) | 5/73 (7%) | 2/31 (6%) | 0/9 (0%) |
Dyspnea | 12/41 (29%) | 19/71 (27%) | 7/31 (23%) | 2/8 (25%) |
Chest pain | 9/41 (22%) | 17/72 (24%) | 7/32 (22%) | 1/8 (13%) |
Palpitations | 17/41 (41%) | 50/98 (51%) | 18/31 (58%) | 4/8 (50%) |
Sinus rhythm | 44/44 (100%) | 78/78 (100%) | 34/34 (100%) | 13/13 (100%) |